MA55504A - Anticorps dirigés contre le liraglutide et leur utilisation - Google Patents
Anticorps dirigés contre le liraglutide et leur utilisationInfo
- Publication number
- MA55504A MA55504A MA055504A MA55504A MA55504A MA 55504 A MA55504 A MA 55504A MA 055504 A MA055504 A MA 055504A MA 55504 A MA55504 A MA 55504A MA 55504 A MA55504 A MA 55504A
- Authority
- MA
- Morocco
- Prior art keywords
- liraglutide
- antibodies against
- antibodies
- against liraglutide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962827444P | 2019-04-01 | 2019-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA55504A true MA55504A (fr) | 2022-02-09 |
Family
ID=70154403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA055504A MA55504A (fr) | 2019-04-01 | 2020-03-31 | Anticorps dirigés contre le liraglutide et leur utilisation |
Country Status (6)
Country | Link |
---|---|
US (2) | US11208477B2 (fr) |
EP (1) | EP3947451A1 (fr) |
JP (1) | JP2022527812A (fr) |
CN (1) | CN113677702A (fr) |
MA (1) | MA55504A (fr) |
WO (1) | WO2020201280A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022140413A1 (fr) * | 2020-12-22 | 2022-06-30 | The Regents Of The University Of Michigan | Anticorps spécifiques de l'amyloïde et utilisations associées |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620850A (en) | 1994-09-26 | 1997-04-15 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
AU5685296A (en) | 1995-05-17 | 1996-11-29 | Novo Nordisk A/S | Immunoassay for glucagon like protein 1 (glp-1) in plasma |
CA2264243C (fr) | 1996-08-30 | 2004-10-05 | Novo Nordisk A/S | Derives de glp-1 |
JP2002505574A (ja) | 1997-04-30 | 2002-02-19 | エンゾン,インコーポレイテッド | ポリアルキレンオキシド修飾された単鎖ポリペプチド |
US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
JP2007534631A (ja) | 2003-10-28 | 2007-11-29 | ノボ ノルディスク アクティーゼルスカブ | ラミニン−5γ2結合性ペプチド、その関連組成物およびその使用 |
MX2007003320A (es) | 2004-09-24 | 2007-05-18 | Amgen Inc | Moleculas fc modificadas. |
TWI372629B (en) | 2005-03-18 | 2012-09-21 | Novo Nordisk As | Acylated glp-1 compounds |
CA2634784A1 (fr) | 2005-12-22 | 2007-07-05 | Centocor, Inc. | Corps mimetiques humains glp-1 et compositions pour traiter l'obesite et les troubles associes, procedes et utilisations |
US8329419B2 (en) | 2008-05-23 | 2012-12-11 | Amylin Pharmaceuticals, Llc | GLP-1 receptor agonist bioassays |
MX2011009797A (es) | 2009-03-20 | 2012-01-12 | Amgen Inc | Inhibidores peptidicos de kv1.3 potentes selectivos. |
WO2012100267A1 (fr) | 2011-01-21 | 2012-07-26 | Ir2Dx, Inc. | Biomarqueurs pour détermination rapide de l'efficacité d'un médicament |
CN104755502B (zh) | 2012-10-12 | 2018-05-18 | 清华大学 | 多肽的产生和纯化方法 |
EP3068891A1 (fr) | 2013-11-13 | 2016-09-21 | Aequus Biopharma Inc. | Glycoprotéines modifiées et leurs utilisations |
AR098615A1 (es) | 2013-12-18 | 2016-06-01 | Lilly Co Eli | Péptido para el tratamiento de hipoglicemia severa |
CN103884846B (zh) | 2014-03-06 | 2016-06-08 | 杭州九源基因工程有限公司 | 一种利拉鲁肽生物学活性的检测方法 |
CN104267194B (zh) | 2014-09-23 | 2016-01-13 | 上海市东方医院 | 人胰高血糖素样肽-1、抗体及其试剂盒 |
GR20140100479A (el) * | 2014-09-23 | 2016-05-05 | Novetide, Ltd., | Συνθεση λιραγλουτιδης |
KR20200044016A (ko) | 2017-08-24 | 2020-04-28 | 노보 노르디스크 에이/에스 | Glp-1 조성물 및 그 용도 |
-
2020
- 2020-03-31 JP JP2021558919A patent/JP2022527812A/ja active Pending
- 2020-03-31 US US16/836,064 patent/US11208477B2/en active Active
- 2020-03-31 MA MA055504A patent/MA55504A/fr unknown
- 2020-03-31 EP EP20716442.7A patent/EP3947451A1/fr active Pending
- 2020-03-31 WO PCT/EP2020/059115 patent/WO2020201280A1/fr unknown
- 2020-03-31 CN CN202080026416.4A patent/CN113677702A/zh active Pending
-
2021
- 2021-11-19 US US17/530,974 patent/US20220064283A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022527812A (ja) | 2022-06-06 |
US20220064283A1 (en) | 2022-03-03 |
EP3947451A1 (fr) | 2022-02-09 |
US11208477B2 (en) | 2021-12-28 |
WO2020201280A1 (fr) | 2020-10-08 |
CN113677702A (zh) | 2021-11-19 |
US20200308274A1 (en) | 2020-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA44776A (fr) | Anticorps anti-vista humain et leur utilisation | |
MA52284A (fr) | Anticorps anti-hla-g et leur utilisation | |
MA52285A (fr) | Anticorps multispécifiques et leur utilisation | |
UA42761S (uk) | Футляр для зберігання та заряджання навушників | |
MA44225A (fr) | Sulfonylurées et composés apparentés et leur utilisation | |
MA47311A (fr) | Anticorps anti-tgf-bêta et leur utilisation | |
MA53434A (fr) | Anticorps anti-tigit | |
MA52884A (fr) | Anticorps anti-il-11 | |
IL279458A (en) | Neoantigens and their uses | |
MA50440A (fr) | Imidazopyridinamides substituées et leur utilisation | |
MA41316A (fr) | Gènes de détermination du sexe et leur utilisation en reproduction | |
MA44056A (fr) | Anticorps anti-rispéridone et leur utilisation | |
MA45709A (fr) | Composés diazahétérobicycliques substitués et leur utilisation | |
IL277447B2 (en) | Cell-adapted exosomes and their uses | |
MA52542A (fr) | Thérapie cellulaire adoptive | |
MA44777A (fr) | Anticorps humanisés anti-basigine et leur utilisation | |
MA52366A (fr) | Anticorps anti-tl1a optimisés | |
UA41767S (uk) | Ємність | |
MA44067A (fr) | Anticorps dirigés contre la quétiapine et utilisation associée | |
MA50038A (fr) | Anticorps anti-pd-l1 de et son utilisation | |
MA52190A (fr) | Anticorps anti-trem-1 et utilisations associées | |
IL284561A (en) | Neoantigens of the prostate and their uses | |
MA51224A (fr) | Composés de sulfonamide et leur utilisation | |
IL287690A (en) | Antibodies against hvem and their use | |
MA49905A (fr) | Polyesteramines et polyesterquats |